D. Wasson

发表

Pyridine nucleotide cycling and poly(ADP-ribose) synthesis in resting human lymphocytes.

D. Carson, S. Seto, D. Wasson, 1987, Journal of immunology.

Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.

T. Kipps, H. Cottam, D. Carson, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Differences in deoxyadenosine metabolism in human and mouse lymphocytes.

J. Kaye, D. Carson, D. B. Wasson, 1980, Journal of immunology.

Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.

D. Richman, D. Carson, T. Haertlé, 1988, Biochemical and Biophysical Research Communications - BBRC.

Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.

S. Williams, D. Martin, M. Hershfield, 1982, The Journal of biological chemistry.

The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts.

J. Kaye, D. Carson, D. Wasson, 1981, Journal of immunology.

Synthesis of 2',3'-dideoxynucleosides by enzymatic trans-glycosylation.

D. Carson, D. B. Wasson, D. Wasson, 1988, Biochemical and biophysical research communications.

Deoxyadenosine-resistant human T lymphoblasts with elevated 5'-nucleotidase activity.

D. Carson, C. Carrera, T. Iizasa, 1991, Biochimica et biophysica acta.

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.

D. Carson, C. Carrera, M. Kubota, 1985, The Journal of clinical investigation.

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.

D. Carson, E. Beutler, D. B. Wasson, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.

R. K. Robins, J. Montgomery, D. Martin, 1980, Proceedings of the National Academy of Sciences of the United States of America.

2-halo-2',3'-dideoxyadenosines: metabolically stable dideoxynucleosides with activity against the human immunodeficiency virus (HIV).

E. H. Willis, D. Richman, D. Carson, 1989, Advances in experimental medicine and biology.

Dependence of cell survival on DNA repair in human mononuclear phagocytes.

D. Carson, C. Carrera, C. Terai, 1991, Journal of immunology.

Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes.

H. Yamanaka, D. Carson, C. Carrera, 1988, Advances in enzyme regulation.

Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.

D. Carson, C. Carrera, M. Kubota, 1984, Biochimica et biophysica acta.

Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.

D. Carson, C. Carrera, S. Seto, 1986, Journal of immunology.

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L 1210 leukemia in vivo ( adenosine deaminase / chemotherapy )

J. Montgomery, J. Kaye, D. Carson, 2022 .

Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

N. Kamatani, D. Carson, E. Lakow, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of an adenosine 5'-triphosphate- and deoxyadenosine 5'-triphosphate-activated nucleotidase from human malignant lymphocytes.

D. Carson, D. Wasson, 1982, Cancer research.

Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency

D. Carson, S. Seto, D. B. Wasson, 1986, The Journal of experimental medicine.

Characterization of human poly(ADP-ribose) polymerase with autoantibodies.

E. H. Willis, H. Yamanaka, C. Penning, 1988, The Journal of biological chemistry.

Metabolic Basis for Immune Dysfunction in Adenosine Deaminase Deficiency a

D. Carson, C. Carrera, M. Kubota, 1985, Annals of the New York Academy of Sciences.

DNA strand breaks, NAD metabolism, and programmed cell death.

D. Carson, C. Carrera, S. Seto, 1986, Experimental cell research.

Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.

D. Richman, D. Carson, T. Haertlé, 1988, The Journal of biological chemistry.

Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.

D. Carson, L. Piro, E. Beutler, 1989, Advances in experimental medicine and biology.

New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.

H. Cottam, D. Carson, G. Di Pasquale, 1993, Journal of medicinal chemistry.

Biochemical basis for deoxyadenosine and 2-chlorodeoxyadenosine toxicity to resting human lymphocytes.

D. Carson, C. Carrera, S. Seto, 1986 .

Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.

A. Yu, D. Carson, R. Taetle, 1983, Blood.

Lymphocyte dysfunction caused by deficiencies in purine metabolism.

N. Kamatani, D. Carson, E. Lakow, 1981, Immunology today.

Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.

N. Kamatani, D. Carson, E. Lakow, 1984, Advances in experimental medicine and biology.

Cell cycle independent lymphocytotoxicity of 2-chlorodeoxyadenosine.

A. Yu, D. Carson, D. Wasson, 1984, Advances in experimental medicine and biology.

Pivotal Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Immunodeficiency and in the Therapy of Chronic Lymphocytic Leukemia

D. Carson, L. Piro, E. Beutler, 1989 .